- Home
- STOK vs CVLG Comparison
STOK vs CVLG Comparison
Compare STOK & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STOK
- CVLG
- Stock Information
- Founded
- STOK 2014
- CVLG 1986
- Country
- STOK United States
- CVLG United States
- Employees
- STOK N/A
- CVLG N/A
- Industry
- STOK Biotechnology: Pharmaceutical Preparations
- CVLG Trucking Freight/Courier Services
- Sector
- STOK Health Care
- CVLG Industrials
- Exchange
- STOK Nasdaq
- CVLG Nasdaq
- Market Cap
- STOK 721.4M
- CVLG 689.1M
- IPO Year
- STOK 2019
- CVLG 1994
- Fundamental
- Price
- STOK $12.03
- CVLG $57.85
- Analyst Decision
- STOK Strong Buy
- CVLG Strong Buy
- Analyst Count
- STOK 7
- CVLG 2
- Target Price
- STOK $21.40
- CVLG $69.50
- AVG Volume (30 Days)
- STOK 405.8K
- CVLG 72.9K
- Earning Date
- STOK 11-05-2024
- CVLG 10-23-2024
- Dividend Yield
- STOK N/A
- CVLG 0.76%
- EPS Growth
- STOK N/A
- CVLG N/A
- EPS
- STOK N/A
- CVLG 3.02
- Revenue
- STOK $16,742,999.00
- CVLG $1,128,130,000.00
- Revenue This Year
- STOK $91.67
- CVLG $5.29
- Revenue Next Year
- STOK $5.45
- CVLG $6.37
- P/E Ratio
- STOK N/A
- CVLG $19.44
- Revenue Growth
- STOK 81.08
- CVLG 0.22
- 52 Week Low
- STOK $3.77
- CVLG $40.73
- 52 Week High
- STOK $17.58
- CVLG $61.54
- Technical
- Relative Strength Index (RSI)
- STOK 39.51
- CVLG 60.46
- Support Level
- STOK $13.39
- CVLG $50.26
- Resistance Level
- STOK $14.72
- CVLG $61.54
- Average True Range (ATR)
- STOK 0.68
- CVLG 1.57
- MACD
- STOK 0.03
- CVLG 0.65
- Stochastic Oscillator
- STOK 7.24
- CVLG 67.29
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
About CVLG Covenant Logistics Group Inc.
Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.